Literature DB >> 22994578

Surveillance program for former PCB-exposed workers of a transformer and capacitor recycling company, family members, employees of surrounding companies, and area residents--executive summary.

Thomas Kraus1, Monika Gube, Jessica Lang, Andre Esser, Walter Sturm, Bruno Fimm, Klaus Willmes, Joseph Neulen, Jens Malte Baron, Hans Merk, Thomas Schettgen, Kerstin Konrad, Sabine Deisz, Lothar Rink, Michael Hagmann, Birgit Fillies, Wolfgang Zschiesche, Jürgen Wittsiepe, Michael Wilhelm.   

Abstract

In a German company polychlorinated biphenyls (PCB)-containing transformers and capacitors were recycled on a large scale. Human biomonitoring revealed a high PCB body burden in workers of the recycling company, in surrounding locations of this plant, in companies in the neighborhood of this plant, and in family members of these employees. In order to clarify whether possible adverse health effects occurred or may occur in the future, a prospective surveillance program was initiated. After an extensive literature search, an interdisciplinary group of experts developed a surveillance program based on current knowledge with respect to possible adverse health effects that might occur in the recycling process of transformers and capacitors. Exposure to various hazardous substances (PCB, polychlorinated dibenzo-p-dioxins and dibenzo-furans [PCDD/F], metals, solvents) was considered. Criteria derived from human biomonitoring results of PCB were used for admission to the program. Participants in the surveillance program are first informed about risks and aims of the program. Subsequently, physicians started a detailed documentation of participants' general and occupational history, with their complaints, diseases, and nutritional habits, as well as information regarding their living areas, by means of a standardized questionnaire. In addition, separate examinations were performed to detect possible neurological, immunological, (neuro)psychological, hormonal, and skin effects. Moreover, DNA exposure as assessed by the comet assay and antioxidative status were determined. The program will be offered at yearly intervals for 3 years, and then at 5 and 10 years after program onset. Until now the program has proved to be feasible, and acceptance among workers and their families has been high. Based on the results, criteria will be developed to define adverse health effects that might be attributable to a hazardous substance exposure.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22994578     DOI: 10.1080/15287394.2012.709377

Source DB:  PubMed          Journal:  J Toxicol Environ Health A        ISSN: 0098-4108


  9 in total

1.  Use of plasma exchange or double filtration plasmapheresis to reduce body burden of polychlorinated biphenyls: A pilot trial.

Authors:  Monika Gube; Thomas Schettgen; Thomas Kraus; Christian Schikowsky; Andreas Heibges; Reinhard Klingel; Christian Hoffmann; Andreas Wiemeyer; Jewgeni Jacobson; André Esser
Journal:  J Expo Sci Environ Epidemiol       Date:  2016-07-20       Impact factor: 5.563

2.  Polychlorinated biphenyls and depression: cross-sectional and longitudinal investigation of a dopamine-related Neurochemical path in the German HELPcB surveillance program.

Authors:  Petra Maria Gaum; Monika Gube; Thomas Schettgen; Franziska Maria Putschögl; Thomas Kraus; Bruno Fimm; Jessica Lang
Journal:  Environ Health       Date:  2017-10-10       Impact factor: 5.984

3.  Telomerase gene expression bioassays indicate metabolic activation of genotoxic lower chlorinated polychlorinated biphenyls.

Authors:  Theresa Vasko; Jenny Hoffmann; Sonja Gostek; Thomas Schettgen; Natalia Quinete; Christian Preisinger; Thomas Kraus; Patrick Ziegler
Journal:  Sci Rep       Date:  2018-11-15       Impact factor: 4.379

4.  Depressive Symptoms After PCB Exposure: Hypotheses for Underlying Pathomechanisms via the Thyroid and Dopamine System.

Authors:  Petra Maria Gaum; Monika Gube; André Esser; Thomas Schettgen; Natalia Quinete; Jens Bertram; Franziska Maria Putschögl; Thomas Kraus; Jessica Lang
Journal:  Int J Environ Res Public Health       Date:  2019-03-16       Impact factor: 3.390

5.  Altered Gene Expression in Dioxin-Like and Non-Dioxin-Like PCB Exposed Peripheral Blood Mononuclear Cells.

Authors:  Marike M Leijs; Lin Gan; Patrick De Boever; André Esser; Philipp M Amann; Patrick Ziegler; Katharina Fietkau; Thomas Schettgen; Thomas Kraus; Hans F Merk; Jens M Baron
Journal:  Int J Environ Res Public Health       Date:  2019-06-13       Impact factor: 3.390

6.  Metabolic activation and toxicological evaluation of polychlorinated biphenyls in Drosophila melanogaster.

Authors:  T Idda; C Bonas; J Hoffmann; J Bertram; N Quinete; T Schettgen; K Fietkau; A Esser; M B Stope; M M Leijs; J M Baron; T Kraus; A Voigt; P Ziegler
Journal:  Sci Rep       Date:  2020-12-09       Impact factor: 4.379

7.  Immunotoxicity Monitoring in a Population Exposed to Polychlorinated Biphenyls.

Authors:  Hajo Haase; Astrid Fahlenkamp; Thomas Schettgen; Andre Esser; Monika Gube; Patrick Ziegler; Thomas Kraus; Lothar Rink
Journal:  Int J Environ Res Public Health       Date:  2016-03-08       Impact factor: 3.390

8.  Accelerated telomere shortening in peripheral blood lymphocytes after occupational polychlorinated biphenyls exposure.

Authors:  Susanne Ziegler; Thomas Schettgen; Fabian Beier; Stefan Wilop; Natalia Quinete; Andre Esser; Behzad Kharabi Masouleh; Monica S V Ferreira; Lucia Vankann; Peter Uciechowski; Lothar Rink; Thomas Kraus; Tim H Brümmendorf; Patrick Ziegler
Journal:  Arch Toxicol       Date:  2016-05-05       Impact factor: 5.153

9.  Human Biomonitoring Data Enables Evidence-Informed Policy to Reduce Internal Exposure to Persistent Organic Compounds: A Case Study.

Authors:  Ann Colles; Dries Coertjens; Bert Morrens; Elly Den Hond; Melissa Paulussen; Liesbeth Bruckers; Eva Govarts; Adrian Covaci; Gudrun Koppen; Kim Croes; Vera Nelen; Nicolas Van Larebeke; Stefaan De Henauw; Tine Fierens; Griet Van Gestel; Hana Chovanova; Maja Mampaey; Karen Van Campenhout; Ilse Loots; Willy Baeyens; Greet Schoeters
Journal:  Int J Environ Res Public Health       Date:  2021-05-22       Impact factor: 3.390

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.